performed genome-wide CRISPR-interference screens in metastatic prostate cancer models and found two prostate cancer-specific driver genes, KIF4A, and WDR62. Both genes induced the phenotypically aggressive prostate cancer in both in vitro and in vivo models (163). The gene discussed is WDR62; the disease is prostate carcinoma.